To simulate clinically adaptive conditions, mice were treated with bevacizumab and paclitaxel until the emergence of resistance, then CSF-1R inhibitors markedly attenuated the function of macrophages and restored the response to anti-angiogenesis treatment, thus causing robust anti-tumor effects [120]. Here, CSF1R is linked to neoplasm.